Pharmacological inhibition of receptor-interacting protein kinase 2 (RIPK2) elicits neuroprotective effects following experimental ischemic stroke

Jonathan Larochelle(University of Florida), Eduardo Candelario‐Jalil(University of Florida)

Experimental Neurology

May 9, 2024

10.1016/j.expneurol.2024.114812

Cited by 7

Related Papers

Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities

|Stroke|2022|839

Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke

|American Journal of Physiology-Cell Physiology|2018|838

Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke

|Frontiers in Neurology|2020|57

Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators

|Journal of Neuroinflammation|2023|31

Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke

|Frontiers in Neuroscience|2018|30